Yokomizo, 1996 - Google Patents
Effects of phospholipids on the percutaneous penetration of drugs through the dorsal skin of the guinea pig, in vitro. 3. The effects of phospholipids on several drugs …Yokomizo, 1996
- Document ID
- 16576102234450215508
- Author
- Yokomizo Y
- Publication year
- Publication venue
- Journal of controlled release
External Links
Snippet
We investigated the influence of several phospholipids (PG derivatives, PC derivatives, and PE derivatives) on the percutaneous penetration of drugs that have different n-octanol/water partition coefficients (log P). The log P-values of several compounds showed the following …
- 150000003904 phospholipids 0 title abstract description 78
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K8/00—Cosmetic or similar toilet preparations
- A61K8/02—Cosmetic or similar toilet preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dubey et al. | Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes | |
| Foldvari | Non-invasive administration of drugs through the skin: challenges in delivery system design | |
| Fang et al. | Effect of liposomes and niosomes on skin permeation of enoxacin | |
| Sato et al. | Effect and mode of action of aliphatic esters on the in vitro skin permeation of nicorandil | |
| Touitou et al. | Liposomes as carriers for topical and transdermal delivery | |
| Parsaee et al. | In-vitro release of diclofenac diethylammonium from lipid-based formulations | |
| HO et al. | The influence of cosolvents on the in‐vitro percutaneous penetration of diclofenac sodium from a gel system | |
| EP0825852B1 (en) | Liposome drug-loading method and composition | |
| DE60126072T2 (en) | LIPID-BASED DRUG DISPENSING SYSTEMS FOR TOPICAL APPLICATION | |
| Hadgraft et al. | Skin penetration of topical formulations of ibuprofen 5%: an in vitro comparative study | |
| Yokomizo et al. | The effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers | |
| Yokomizo et al. | Effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pigs in vitro | |
| Sakdiset et al. | Selection of phospholipids to design liposome preparations with high skin penetration-enhancing effects | |
| Hermann et al. | Topical ciclosporin for psoriasis: in vitro skin penetration and clinical study | |
| CA1308025C (en) | Phospholipid composition | |
| Valenta et al. | Effect of phloretin on the percutaneous absorption of lignocaine across human skin | |
| US20220054370A1 (en) | Multilayered cationic liposome for enhancing skin absorption and preparation method therefor | |
| Yokomizo | Effects of phospholipids on the percutaneous penetration of drugs through the dorsal skin of the guinea pig, in vitro. 3. The effects of phospholipids on several drugs having different polarities | |
| PT1551370E (en) | Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin | |
| Zografi et al. | Surface activity of chlorpromazine and chlorpromazine sulfoxide in the presence of insoluble monomolecular films | |
| Ita et al. | Dermal delivery of selected hydrophilic drugs from elastic liposomes: effect of phospholipid formulation and surfactants | |
| Fang et al. | Capsaicin and nonivamide as novel skin permeation enhancers for indomethacin | |
| Yokomizo | Effect of phosphatidylcholine on the percutaneous penetration of drugs through the dorsal skin of guinea pigs in vitro; and analysis of the molecular mechanism, using attenuated total reflectance-Fourier transform infrared (ATR-FTIR) spectroscopy | |
| Vávrová et al. | Permeation enhancer dodecyl 6-(dimethylamino) hexanoate increases transdermal and topical delivery of adefovir: influence of pH, ion-pairing and skin species | |
| Paraskevopoulos et al. | Effects of imidazolium ionic liquids on skin barrier lipids–Perspectives for drug delivery |